Ece Mutlu, MD
Gastroenterology · Chicago, ILNPI 1598707911
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,164 of the $1,605 with a category attached, or 72.5%. Medtronic accounts for 84.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $1,019 and has fallen 51.2% since, to $497 in 2025.
Across 19 payments — averaging $84.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Janssen Scientific Affairs, LLC$116
- Johnson & Johnson$89
- Ironwood Pharmaceuticals, Inc$52
Across 99 payments — averaging $1308.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$94K
- UCB Biosciences Inc.$25K
- Janssen Research & Development, LLC$11K
- Shire North American Group Inc$750
What the payments were for
- Travel & lodging$1,16473%
- Food & beverage$35222%
- Education$896%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 16 | $1,348 |
| Janssen Scientific Affairs, LLC | 1 | $116 |
| Johnson & Johnson | 1 | $89 |
| Ironwood Pharmaceuticals, Inc | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,605 in reported general payments places this provider in the 55th percentile of 787 gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azathioprine | 11 | $378 |
| Omeprazole | 22 | $368 |
| Pantoprazole Sodium | 13 | $129 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Chicago
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Darren BrennerChicago$1.1M
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
- Christopher ChapmanChicago$645K
- Saurabh KapurChicago$532K
- Ikuo HiranoChicago$457K
- Adam SteinChicago$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.